Interview with Bulent Denkdemir, General Manager, Hedef Alliance Turkey
You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I would say that there…
Address: Basın Ekspres Yolu, Kavak Sok. Ser Plaza, Yenibosna – İstanbul,Turkey
Tel: 0 212 452 72 00
Web: http://www.hedefalliance.com/
The main objective is to add value to human health and the beauty of the Target Holding’s main business area of Alliance, to provide distribution services to pharmacies, pharmaceutical and perfumery. Target Pharmacy in Turkey, Esko Perfumery and cosmetics companies, comprising Target Vision Alliance partners in the region with 57 700 in Egypt and Algeria, pharmacy, pharmaceutical warehouse and approximately 11,000 employees and serves 149.
Distribution services to pharmacies, pharmaceutical and perfumer
You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I would say that there…
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their portfolio from China, general manager Arafat Yadigar is looking to develop a…
Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set, J&J’s commitment to quality and his ambition for the company’s…
Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s…
Matthias Diewald (MD) and Asli Volkan (AV) elaborate on HELM Kimya’s longstanding presence within Turkey and the type of market opportunities available for co-development and contract manufacturing. They also explain the…
Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as how to penetrate the global pharmaceutical market…
Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to address critical future needs of the…
BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer, their registry of 1200 patients in Turkey with melanoma, potential developments in pharmaceutical…
Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish pharmaceutical market. Turkish R&D spending amounted to just 0.95…
Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in Turkey are constructed from the lowest price in…
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of Health Mehmet Müezzinoğlu gave PharmaBoardroom. This is the beginning…
Recep Altekin, the general manager of MT Sağlik – market leader in Turkey for blood glucose monitoring systems and diabetes test strips by volume – tells PharmaBoardroom about his company’s impact…
AstraZeneca’s Country President for Turkey discusses their efforts to build scientific leadership in Turkey in line with their global strategy and her hopes for the market access and public-private partnership…
See our Cookie Privacy Policy Here